Kirk Tanner

Kirk Tanner is a seasoned professional in the field of clinical development and drug discovery, currently serving as SVP of Clinical Development at Autem Therapeutics since January 2025. Prior to this role, Tanner held several prominent positions at the National Brain Tumor Society, including Senior Vice President of the Brain Tumor Investment Fund and Chief Scientific Officer. Tanner's experience at Vertex Pharmaceuticals spans over a decade, with titles such as Senior Research Fellow, Senior Research Scientist, and Research Scientist I, specializing in oncology and drug discovery. Tanner earned a PhD in Chemistry and Biochemistry from UC San Diego and a BS in Chemistry and Biochemistry from California State University, Fullerton.